Results

Total Results: 659 records

Showing results for "mentioned".

61. Disposition of Comments_Comparative Effectiveness Review NO. 243: Prehospital Airway Management (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/cer-243-prehospital-airway-management-disposition-comments.pdf
    June 14, 2021 - This is mentioned in the Discussion section, "Studies did not always clearly identify whether other … This is mentioned in the Discussion section, "Studies did not always clearly identify whether other … One vs two-person concern was mentioned in the KQ1 Discussion. … One vs two-person concern was mentioned in the KQ1 Discussion.

62. Evidence-based Practice Center Systematic Review Protocol (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/breast-cancer-medications_disposition-comments.pdf
    March 10, 2010 - Later it is mentioned as a major reason for nonadherence. 2. pES-4, line 16. … The 10% threshold is mentioned, but it is not clear if this is 10% more than in the placebo group? … Is this the same as the Gail 2 mentioned earlier? … In several of these sentences, the specific RR should be mentioned for each subgroup. … There's not much literature available on this but it might be mentioned, as a limiting factor of the

63. Disposition of comments_Comparative Effectiveness Review No. 242: Radiation Therapy for Brain Metastases (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/cer-242-radiation-therapy-brain-metastases-disposition-comments.pdf
    June 09, 2021 - certainly true that clinicians use a nuanced framework incorporating a number of factors such as those mentioned … Peer Reviewer #1 Results Page 24 of 280 WBRT plus radiosensitizers- It is mentioned there are 5 … Outcomes for the factors mentioned (histologic subtype, tumor number and tumor volume) were abstracted … Instead, we would recommend combining WBRT plus memantine with WBRT plus hippocampal avoidance (mentioned … than just providing something as important as the definition of strength of evidence when first mentioned

64. Disposition of Comments Report for Comparative Effectiveness of Bariatric Surgery and Nonsurgical Therapy in Adults With Metabolic Conditions and a Body Mass Index of 30.0 to 34.9 kg/m2 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/weight-loss-surgery_disposition-comments.pdf
    June 05, 2013 - Would recommend putting this in the Introduction. this is mentioned in the body of the article (table … TEP 1 Results There is an Australian cohort study mentioned in the discussion. … The media reports are mentioned in the “discussion” section, as an example of the often heard concern … We have mentioned this in the Introduction in the section describing the bariatric surgery procedures … Liraglutide is mentioned in the introduction under Nonsurgical Interventions and data are presented

65. Evidence-based Practice Center Systematic Review Protocol (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/atypical-antipsychotics-off-label-update_disposition-comments.pdf
    September 01, 2011 - approval for aripiprazole in the treatment of irritability associated with autistic disorder was not mentioned … BMS Results - KQ1 40 On page 40, it is mentioned for the Cooper study that new users of antipsychotics … Executive Summary, p. 4; Table 1; These approvals are mentioned in the introduction. … These approvals are mentioned in the introduction. … There are no quetiapine trials mentioned.

66. Comparative Effectiveness Review Disposition of Comments Report (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/bundled-payments-quality-effects_disposition-comments.pdf
    August 24, 2012 - paragraph of the ""Background"" section on undesired effects of bundled payments, in addition to what is mentioned … , it would be worth mentioning:--unbundling (mentioned on p. 11)--spillover effects (from p. 74)--upcoding … (mentioned on p. 11)It would be useful in the ES to summarize the evidence on these adverse effects … Are there differences in the population not mentioned in the report? … One thing I thought was missing, though it is mentioned at the end, is a discussion about how current

67. Treatment for Restless Legs Syndrome Disposition of Comments Report (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/restless-legs_disposition-comments.pdf
    November 27, 2012 - 10 (line 8) and pg 33 (line 33): The extensive work on the genetic basis of primary RLS should be mentioned … There are others than what is mentioned in the table..... We mainly focused on the RLS-QoL. … different dosing from what is available to treat hyperprolactinemia, and lack of familiarity, not, as is mentioned … Most point i.e. no studies in pregnancy are mentioned more than 5 times. … This needs to be mentioned as there is a very strong correlation between CGI results and IRLS results

68. Disposition of Comments Report for The Effectiveness and Risks of Long-Term Opioid Treatment of Chronic Pain (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/chronic-pain-opioid-treatment_disposition-comments.pdf
    September 29, 2014 - distinction and carry it through the entire manuscript when the phrase “maximum dose ceiling(s)” is mentioned … The mentioned reviews and others are Discussed for contextual purposes. … Peer Reviewer 7 Introduction Page ES-1, lines 29-30-Ref 25 is about hyperalgesia-this should be mentioned … Peer Reviewer 11 Results As mentioned above, I view harms along a spectrum: from misuse, abuse, overdose … Accordingly, as mentioned in section 2 above, the conclusions of the report need to be qualified by

69. Disposition of Comments for CER 167 Renal Masses (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/renal-cancer_disposition-comments.pdf
    February 24, 2016 - As mentioned above, consideration should be made to analyze these. … iii.The data note a difference in undiagnosed and treated SRMs. this should be mentioned in with the … This should be added to the above mentioned statement. … On several occasions single studies are mentioned (for example on page 55) with no reported results, … This comment is consistent with the limitations we have mentioned in the report.

70. Disposition of Comments Report for Stroke Prevention in Atrial Fibrillation (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/stroke-atrial-fibrillation_disposition-comments.pdf
    August 23, 2013 - Acknowledged TEP #6 General: Clarity and usability As mentioned previously, this report is very … All but one of the studies utilizing Framingham risk explicitly mentioned that they had actual blood … Since apixaban has now received FDA approval, we have not altered the sentence specifically mentioned … TEP #2 Methods As mentioned above, the authors should be clear about describing the c-statistic as a … Some of the remaining issues and questions regarding these new agents are mentioned here.

71. Partial Breast Irradiation for Breast Cancer (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/partial-breast-irradiation-disposition-comments.pdf
    January 31, 2023 - ASTRO) General Minor Points: Table 1 – mention sexual health but no scale in the table nor is it mentioned … There are tens of subgroup analyses (such as the ones mentioned in the comment) that are not feasible

72. Disposition of Comments for CER 159 Insomnia (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/insomnia_disposition-comments.pdf
    December 30, 2015 - There is another kind of adverse evidence, evidence of post- drug-withdrawal insomnia, which is not mentioned … Peer Reviewer 1 Methods The previous reviews mentioned on page 33, lines 15-27, have demonstrated that … Peer Reviewer 10 Results - secondary outcomes - again, these are barely mentioned but are probably the … This is mentioned above (see my comments in methods). … We have mentioned this in our discussion: ‘Trials meeting our inclusion criteria were predominantly

73. Disposition of Comments Report for Relationship Between Use of Quality Measures and Improved Outcomes in Serious Mental Illness (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/mental-illness-outcomes_disposition-comments.pdf
    January 15, 2015 - Such a consideration is mentioned on page 20 GQ4b and in the Next Steps section. … We have made this change in the specific spot mentioned. … At a minimum, these efforts should be mentioned. … (no specific use as a QM was mentioned. … (no specific use as a QM was mentioned.

74. Disposition of Comments Report for Multigene Panels in Prostate Cancer Risk Assessment (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/prostate-cancer-risk-assessment-genes_disposition-comments.pdf
    July 03, 2012 - These should be listed and mentioned if they exist. Thank you for your comment. … As mentioned in response to “General Comments”, we have added consideration of this work in the Discussion

75. Disposition of Comments_CER 241: Physical Activity and the Health of Wheelchair Users: A Systematic Review in Multiple Sclerosis, Cerebral Palsy, and Spinal Cord Injury (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-241-wheelchair-users-disposition-comments.pdf
    October 18, 2022 - This is also mentioned in the section on Limitations of the Systematic Review Process. … This is also mentioned in the section on Limitations of the Systematic Review Process.

76. Disposition of Comments Report for Comparative Effectiveness Review No. 131 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/crohns-disease_disposition-comments.pdf
    February 25, 2014 - TEP-1 Clarity and usability Line 46, calling out PML is a little from left field; not mentioned in … TEP-2 General comments In several instances comparisons for “response” are mentioned. … TEP-2 General comments At no point is definition of “moderate-severe” Crohn’s disease mentioned. … TEP-2 Introduction; abstract No mention of natalizumab as maintenance Natalizumab is mentioned in … We revised the order and tables as mentioned previously.

77. Options for Developing a Web-Based Forum on Patient Registries (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/registries-forums_research_0.pdf
    May 01, 2014 - Secondary goals mentioned by stakeholders included facilitating networking, interaction, and collaboration … Topics of “some interest” were mentioned by two to four stakeholders, and topics of “less interest” … were mentioned by a single stakeholder. … Additional Features The following features were not mentioned by stakeholders as essential features … While they are less critical than the five features mentioned previously in this section, they could

78. CER 205 Disposition of Comments for Physiologic Predictors of Severe Injury: A Systematic Review (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-205-predictors-trauma-care-disposition-comments.pdf
    April 01, 2018 - An increase in relevant publications in the last decade is mentioned in the manuscript. … The Trauma chain of survival is mentioned. Figure 1 comes from the British Journal of Surgery. … Children are often overtriaged, as was mentioned.

79. Disposition of Comments for Imaging Tests for the Staging of Colorectal Cancer (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/colorectal-cancer-staging_disposition-comments.pdf
    November 20, 2014 - Should 3-D ultrasound be mentioned? Thank you for noticing this omission. … It might be appropriate to state that the screening mentioned is for the general population and that … As mentioned above, for KQ 1.a., it seems reasonable to include both the high-quality reviews and primary … Comment: page 35/231 line 35-39, Color Doppler imaging is not widely available and such should be mentioned … included by IQWiG but are not mentioned in the AHRQ report: b.

80. Disposition of Comments_CER 231 Care Interventions for People Living With Dementia and Their Caregivers (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-231-dementia-care-interventions-disposition-comments.pdf
    July 31, 2020 - Earlier in the report, REACH-II was mentioned by name. … (If any models mentioned by name are commercial/for-profit, that fact should be stated). … (If any models mentioned by name are commercial/for-profit, that fact should be stated). … Many of the limitations and gaps in the research literature mentioned by the authors may also present … There is little attention in the draft report to non-Alzheimer’s dementias; they are however mentioned